1. The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
- Author
-
Anthony Howell, Eleanor Roberts, William G. Newman, Adam R. Brentnall, Helen Byers, Jack Cuzick, Elaine F. Harkness, Elke M van Veen, D. Gareth Evans, and Sacha J Howell
- Subjects
Adult ,Cancer Research ,Ethnic group ,Breast Neoplasms ,Polymorphism, Single Nucleotide ,White People ,Breast cancer ,European origin ,Risk Factors ,Biomarkers, Tumor ,Ethnicity ,medicine ,Humans ,Genetic Predisposition to Disease ,Aged ,Breast Density ,White (horse) ,business.industry ,Carcinoma, Ductal, Breast ,Cancer ,Middle Aged ,Ductal carcinoma ,Prognosis ,medicine.disease ,Carcinoma, Intraductal, Noninfiltrating ,England ,Oncology ,Case-Control Studies ,Disease risk ,Female ,Polygenic risk score ,business ,Follow-Up Studies ,Demography - Abstract
Polygenic risk scores (PRS) for disease risk stratification show great promise for application in general populations, but most are based on data from individuals of white European origin. We assessed two well validated PRS (SNP18, SNP143) in the Predicting-Risk-of-Cancer-At-Screening (PROCAS) study in North-West England for breast cancer prediction based on ethnicity. Overall, 9475 women without breast cancer at study entry, including 645 who subsequently developed invasive breast cancer or ductal carcinoma in situ provided DNA. All were genotyped for SNP18 and a subset of 1868 controls were genotyped for SNP143. For white Europeans both PRS discriminated well between individuals with and without cancer. For n=395 Black (n=112), Asian (n=119), mixed (n=44) or Jewish (n=120) women without cancer both PRS overestimated breast cancer risk, being most marked for women of Black and Jewish origin (p
- Published
- 2021
- Full Text
- View/download PDF